BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35763977)

  • 1. Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery.
    Fernandes BS; Dai Y; Jia P; Zhao Z
    Eur Neuropsychopharmacol; 2022 Aug; 61():43-59. PubMed ID: 35763977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder.
    Chang SH; Gao L; Li Z; Zhang WN; Du Y; Wang J
    Biol Psychiatry; 2013 Nov; 74(10):727-33. PubMed ID: 23764453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three major psychiatric disorders share specific dynamic alterations of intrinsic brain activity.
    Zhang L; Zhang R; Han S; Womer FY; Wei Y; Duan J; Chang M; Li C; Feng R; Liu J; Zhao P; Jiang X; Wei S; Yin Z; Zhang Y; Zhang Y; Zhang X; Tang Y; Wang F
    Schizophr Res; 2022 May; 243():322-329. PubMed ID: 34244046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies.
    Marx W; McGuinness AJ; Rocks T; Ruusunen A; Cleminson J; Walker AJ; Gomes-da-Costa S; Lane M; Sanches M; Diaz AP; Tseng PT; Lin PY; Berk M; Clarke G; O'Neil A; Jacka F; Stubbs B; Carvalho AF; Quevedo J; Soares JC; Fernandes BS
    Mol Psychiatry; 2021 Aug; 26(8):4158-4178. PubMed ID: 33230205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiological Commonalities and Distinctions Among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study.
    Chang M; Womer FY; Edmiston EK; Bai C; Zhou Q; Jiang X; Wei S; Wei Y; Ye Y; Huang H; He Y; Xu K; Tang Y; Wang F
    Schizophr Bull; 2018 Jan; 44(1):65-74. PubMed ID: 29036668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Regulatory Network of Dorsolateral Prefrontal Cortex: a Master Regulator Analysis of Major Psychiatric Disorders.
    Bristot G; De Bastiani MA; Pfaffenseller B; Kapczinski F; Kauer-Sant'Anna M
    Mol Neurobiol; 2020 Mar; 57(3):1305-1316. PubMed ID: 31728928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local functional connectivity alterations in schizophrenia, bipolar disorder, and major depressive disorder.
    Wei Y; Chang M; Womer FY; Zhou Q; Yin Z; Wei S; Zhou Y; Jiang X; Yao X; Duan J; Xu K; Zuo XN; Tang Y; Wang F
    J Affect Disord; 2018 Aug; 236():266-273. PubMed ID: 29751242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder.
    Yang Y; Liu S; Jiang X; Yu H; Ding S; Lu Y; Li W; Zhang H; Liu B; Cui Y; Fan L; Jiang T; Lv L
    Front Psychiatry; 2019; 10():52. PubMed ID: 30837901
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
    Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders.
    Dean B; Gibbons AS; Tawadros N; Brooks L; Everall IP; Scarr E
    Mol Psychiatry; 2013 Jul; 18(7):767-73. PubMed ID: 22801413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls.
    Morisano D; Wing VC; Sacco KA; Arenovich T; George TP
    Am J Addict; 2013 Jan; 22(1):46-53. PubMed ID: 23398226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders.
    Tsermpini EE; Kalogirou CI; Kyriakopoulos GC; Patrinos GP; Stathopoulos C
    Pharmacogenomics J; 2022 Jul; 22(4):211-222. PubMed ID: 35725816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
    David FS; Stein F; Andlauer TFM; Streit F; Witt SH; Herms S; Hoffmann P; Heilmann-Heimbach S; Opel N; Repple J; Jansen A; Nenadić I; Papiol S; Heilbronner U; Kalman JL; Schaupp SK; Senner F; Schulte EC; Falkai PG; Schulze TG; Dannlowski U; Kircher T; Rietschel M; Nöthen MM; Krug A; Forstner AJ
    Schizophr Res; 2023 Feb; 252():161-171. PubMed ID: 36652833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Plasma Biomarkers with high specificity for major depressive disorder: A multi-level proteomics study.
    Shi Y; Song R; Wang L; Qi Y; Zhang H; Zhu J; Zhang X; Tang X; Zhan Q; Zhao Y; Swaab DF; Bao AM; Zhang Z
    J Affect Disord; 2020 Dec; 277():620-630. PubMed ID: 32905914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder.
    Zhu Y; Womer FY; Leng H; Chang M; Yin Z; Wei Y; Zhou Q; Fu S; Deng X; Lv J; Song Y; Ma Y; Sun X; Bao J; Wei S; Jiang X; Tan S; Tang Y; Wang F
    Front Psychiatry; 2019; 10():253. PubMed ID: 31105603
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder.
    Song Y; Yang J; Chang M; Wei Y; Yin Z; Zhu Y; Zhou Y; Zhou Y; Jiang X; Wu F; Kong L; Xu K; Wang F; Tang Y
    Front Psychiatry; 2022; 13():993356. PubMed ID: 36186868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review.
    MacDonald K; Krishnan A; Cervenka E; Hu G; Guadagno E; Trakadis Y
    Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):122-137. PubMed ID: 30411484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.